{"retracted":false,"update":{"timestamp":1477958400000,"doi":"10.1016/j.ejca.2016.09.002","type":"err"},"doi":"10.1016/j.ejca.2016.01.005","journal":"European Journal of Cancer","publisher":"Elsevier BV","title":"Corrigendum to “Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation” [Eur J Cancer 57 (April 2016) 118–126]"}
